Pfizer Inc.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin f…
Insiders
Transactions
| Reported Owner(s) | Position Now | Transaction Date | Type | Position Change | Extra | ||
|---|---|---|---|---|---|---|---|
|
$100,000,000
d
cs
10% Holder
|
10/30/24 |
P
|
10,000,000 x $28.24 = $282,400,000.00 |
Footnotes
|
|||
|
$295,480,000
d
cs
10% Holder
|
08/31/24 |
F
|
201,950,000 x $29.01 = $5,858,569,500.00 |
Footnotes
#1 The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
#2 Price is the closing price of Pfizer common stock on August 30, 2024.
|
|||
|
$85,820,000
d
cs
10% Holder
|
08/13/24 |
S
|
51,540,000 x $28.66 = $1,477,136,400.00 |
Footnotes
|
|||
|
$379,190,000
d
cs
10% Holder
|
05/31/24 |
F
|
121,070,000 x $28.66 = $3,469,866,200.00 |
Footnotes
#1 The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
|
|||
|
$1,601,570,000
d
cs
10% Holder
|
02/28/24 |
A
|
115,100,000 x $0 = $0 |
Footnotes
#1 The reported transaction constitutes the earn-out of performance share awards (including dividend equivalents thereon).
#2 The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of performance share awards (including dividend equivalents thereon).
|
|||
Get PRO Today
With PRO you will unlock 39 more insider transactions for Pfizer Inc.
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Baum Andrew Executive Vice President
- Blaylock Ronald E Director
- Boshoff Christoffel Executive Vice President
- Bourla Albert Chairman & CEO
- Buckley Mortimer J Director
- Damico Jennifer B. SVP & Controller
- De Germay Alexandre Executive Vice President
- Denton David M Chief Financial Officer & EVP
- Desmond-Hellmann Susan Director
- Dolsten Mikael President R&D
- Echevarria Joseph Director
- Fonseca Lidia Executive Vice President
- Gottlieb Scott Director
- Hobbs Helen Director
- Hockfield Susan Director
- Johnson Rady A Executive Vice President
- Lankler Douglas M Executive Vice President
- Littman Dan R. Director
- Malik Aamir Executive Vice President
- Mcdermott Michael Executive Vice President
- Narayen Shantanu Director
- Nora Johnson Suzanne M Director
- Quincey James Chairman and CEO
- Sahni Payal Executive Vice President
- Smith James C Director
- Susman Sally Executive Vice President
- Taraporevala Cyrus Director
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Baum Andrew Executive Vice President
- Blaylock Ronald E Director
- Boshoff Christoffel Executive Vice President
- Bourla Albert Chairman & CEO
- Buckley Mortimer J Director
- Damico Jennifer B. SVP & Controller
- De Germay Alexandre Executive Vice President
- Denton David M Chief Financial Officer & EVP
- Desmond-Hellmann Susan Director
- Dolsten Mikael President R&D
- Echevarria Joseph Director
- Fonseca Lidia Executive Vice President
- Gottlieb Scott Director
- Hobbs Helen Director
- Hockfield Susan Director
- Johnson Rady A Executive Vice President
- Lankler Douglas M Executive Vice President
- Littman Dan R. Director
- Malik Aamir Executive Vice President
- Mcdermott Michael Executive Vice President
- Narayen Shantanu Director
- Nora Johnson Suzanne M Director
- Quincey James Chairman and CEO
- Sahni Payal Executive Vice President
- Smith James C Director
- Susman Sally Executive Vice President
- Taraporevala Cyrus Director